What is Pfizer Ltd (PFIZER) share price today?

Pfizer Ltd (PFIZER) is listed on the NSE. Visit VestAI at https://www.vestai.io/stocks/PFIZER for the latest live price, technical analysis, and AI-powered insights.

How to analyse PFIZER stock?

VestAI provides comprehensive PFIZER stock analysis including RSI, MACD, Bollinger Bands, SMA trend, ROCE, debt-to-equity ratio, and smart money holdings by superstar investors.

What sector is Pfizer Ltd in?

Pfizer Ltd (PFIZER) is in the Healthcare sector, Pharmaceuticals industry on the NSE.

Pfizer Ltd

Name: Pfizer Ltd (PFIZER) Financial Metrics
Creator: VestAI

PFIZER

NSE· Healthcare

₹4,563.00

-3.90 (-0.09%)

Updated 08:15 am IST

52W Low · ₹4,360.1052W High · ₹5,873.50

Near 52W Low

Market Cap

₹20386.56L Cr

Volume

5.5K

Prev Close

₹4,697.80

ISIN

INE182A01018

Orion Score

Fundamentals-based quality & risk · not a recommendation

64/100

Watch

Pfizer Ltd scores 64/100 (Watch) on the Orion Score — strong business quality (81), poor growth (23), strong balance-sheet safety (92) and rich valuation (33). A fundamentals-based quality & risk score, not a buy/sell recommendation.

Quality

Growth

Safety

Value

Full Orion analysis

Risk checks

Profit converts to cash (CFO 0.9× PAT)
Low debt, comfortable interest cover
No distress, manipulation or dilution flags

Forensic accounting

Piotroski F 5/9Altman Z Safe(11.34)Beneish M Clean(-2.76)

Piotroski F = fundamental health (0–9, higher is better) · Altman Z = bankruptcy / distress risk · Beneish M = earnings-manipulation check

Technical / Momentum

Price Trend

29/100

Weak

Technical momentum companion — separate from the fundamentals-based Orion Score.

Unlock with Pro

Upgrade →

VestAI Stock Score

VALUATION

Low Debt

D/E 0.02x — lean balance sheet

QUALITY

Average

ROCE 19.7% — decent returns

MOMENTUM

Neutral

RSI 47.1 — consolidating

Price Chart

SMA 20

SMA 50

SMA 200

Key Fundamentals

Q4 FY2026

P/E Ratio: 28.25
ROCE: 19.71%
ROE (1Y): 17.16%
D/E Ratio: 0.02x
OPM: 35.15%
TTM EPS: ₹157.75
Dividend Yield: 168.00%
Qtrly Sales: ₹629.23 Cr
Qtrly Profit: ₹199.82 Cr

Technical Signals

Quarterly Results

Revenue & Profit in ₹ Crores

Revenue Net Profit

Quarter	Revenue	Net Profit	OPM	EPS
Q4 2026	₹629.23	₹199.82	35.1%	₹43.68
Q3 2026	₹645.03	₹141.84	33.2%	₹31.01
Q2 2026	₹642.34	₹189.02	33.6%	₹41.32
Q1 2026	₹603.05	₹191.75	32.4%	₹41.91
Q4 2025	₹591.91	₹330.94	35.7%	₹72.34

Annual P&L

Revenue & Profit in ₹ Crores (Yearly)

Revenue Net Profit

Year	Revenue	Net Profit	EBITDA	OPM
FY 2026	₹2,519.65	₹722.43	₹1,042.88	33.6%
FY 2025	₹2,281.35	₹767.6	₹1,085.29	29.8%
FY 2024	₹2,192.69	₹551.33	₹823.76	26.3%
FY 2023	₹2,422.32	₹623.93	₹942.91	29.3%

Peer Comparison — Healthcare

Top companies in the same sector by market cap

Company	Mkt Cap	P/E	ROCE	ROE	D/E	OPM
PFIZER ★	₹20,387 Cr	28.25	19.71%	17.16%	0.02x	35.15%
SUNPHARMASun Pharmaceutical Industries	₹4,27,609 Cr	37.32	15.73%	14.72%	0.06x	18.90%
MAXHEALTHMax Healthcare Institute	₹95,110 Cr	66.21	11.94%	14.33%	0.32x	22.56%
AUROPHARMAAurobindo Pharma Limited	₹88,228 Cr	25.64	12.55%	9.93%	0.21x	15.11%
ASTERDMAster DM Quality	₹71,372 Cr	108.60	8.93%	10.07%	0.46x	13.98%
ABBOTINDIAAbbott India Limited	₹59,615 Cr	38.42	36.14%	34.46%	0.04x	27.01%

Balance Sheet

All values in ₹ Crores

Metric	FY 2025	FY 2024	FY 2023	FY 2022
Total Assets	₹4,911.11	₹4,228.78	₹4,000.73	₹3,900.51
Equity	₹4,217.41	₹3,595.54	₹3,207.3	₹2,864.41
Total Debt	₹108.4	₹94.54	₹134.47	₹166.99
Cash	₹495.07	₹112	₹36.6	₹62.76
Net Debt	—	—	—	—
Working Capital	₹2,943.34	₹2,223	₹1,867.74	₹1,543.59

Shareholding Pattern

Q1 FY2027

Promoter

66.97%

FII

9.33%

DII

7.63%

Public

16.07%

Quarter-over-Quarter Trend

Quarter	Promoter	FII	DII	Public
Q1 FY2027	66.97% ↑	9.33% ↑	7.63% ↓	16.07% ↓
Q3 FY2026	63.92%	2.71% ↑	17.05% ↓	16.32% ↓
Q2 FY2026	63.92%	2.6% ↑	17.11% ↓	16.37% ↓
Q1 FY2026	63.92%	2.4% ↑	17.23% ↑	16.45% ↓
Q4 FY2025	63.92%	2.18% ↓	17.1% ↑	16.79% ↑
Q3 FY2025	63.92%	2.74% ↓	16.8% ↑	16.54% ↑
Q2 FY2025	63.92%	3.54% ↑	16.03% ↑	16.5% ↓
Q1 FY2025	63.92%	3.22%	15.83%	17%

Corporate Actions

Ex-Date	Action	Details
2026-07-17	DIVIDEND	Dividend - Rs 75 Per Share

Funds Holding This Stock

72 mutual fund schemes

Quant Healthcare Fund Direct GrowthESCORTS

5.92%

₹22 Cr

NJ ELSS Tax Saver Scheme Direct GrowthNJ

3.22%

₹11 Cr

DSP Healthcare Fund Direct GrowthDSP

2.79%

₹92 Cr

Aditya Birla Sun Life MNC Fund Direct GrowthBIRLA_SUN_LIFE

2.18%

₹71 Cr

Samco ELSS Tax Saver Fund Direct GrowthSamco MF

2.17%

₹2 Cr

ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct GrowthICICI_PRUDENTIAL

1.98%

₹128 Cr

Samco Small Cap Fund Direct GrowthSamco MF

1.94%

₹3 Cr

Bandhan Healthcare Fund Direct GrowthIDFC

1.92%

₹6 Cr

ICICI Prudential Smallcap Fund Direct Plan GrowthICICI_PRUDENTIAL

1.88%

₹168 Cr

HDFC MNC Fund Direct GrowthHDFC

1.85%

₹10 Cr

Analyse PFIZER with Orion AI

Ask: "Is Pfizer Ltd stock a good buy right now?" — Get RSI, MACD, ROCE + AI recommendation

Analyse with Orion

Want more insights like this?

Get free stock analysis, market insights, and investment ideas delivered to your inbox.

No spam. Unsubscribe anytime.

About Pfizer Ltd (PFIZER) Stock

Pfizer Ltd is listed on the NSE under the Healthcare sector, Pharmaceuticals industry. ISIN: INE182A01018. Track live share price, technical analysis, RSI, MACD, PE ratio, and smart money holdings on VestAI — India's AI-powered stock analysis platform.